A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer-Reference-Cited by-同舟云学术

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer

Published:2001-10 Issue:1 Volume:34 Page:133-139
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Agelaki S.,Kakolyris S.,Palamidas Ph.,Kouroussis Ch.,Mavroudis D.,Kalbakis K.,Georgoulias V.,Raptis A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Current management of small cell lung cancer;Sadler;Semin. Oncol.,1997

2. Overview of chemotherapy for small cell lung cancer;Bunn;Semin. Oncol.,1997

3. Predictors of survival following relapse or progression of small cell lung cancer;Albain;Cancer,1993

4. Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group Study;Ettinger;J. Clin. Oncol.,1995

5. Docetaxel (taxotere) in extensive stage small cell lung cancer (SCLC): a phase II trial of the Southwest Oncology Group (SWOG);Burris;Proc. Am. Soc. Clin. Oncol. (Abstract),1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical determination of epirubicin in the presence of topotecan as essential anti-cancer compounds using paste electrode amplified with Pt/SWCNT nanocomposite and a deep eutectic solvent;Chemosphere;2022-02

2. Treatment of relapsed small-cell lung cancer—a focus on the evolving role of topotecan;Lung Cancer;2003-06

3. Topoisomerase I interactive agents;Cancer Chemotherapy and Biological Response Modifiers Annual;2003